{"title":"CDK4/6活性合成抑制剂与肿瘤抑制:特刊前言","authors":"C. Takahashi, J. Kato","doi":"10.3390/ONCO1010001","DOIUrl":null,"url":null,"abstract":"The status of RB1 in cancer may help us determine the optimal therapeutic approach to patients [...]","PeriodicalId":74339,"journal":{"name":"Onco","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3390/ONCO1010001","citationCount":"0","resultStr":"{\"title\":\"Synthetic Inhibitors of CDK4/6 Activities and Tumor Suppression: A Preface to the Special Issue\",\"authors\":\"C. Takahashi, J. Kato\",\"doi\":\"10.3390/ONCO1010001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The status of RB1 in cancer may help us determine the optimal therapeutic approach to patients [...]\",\"PeriodicalId\":74339,\"journal\":{\"name\":\"Onco\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3390/ONCO1010001\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Onco\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/ONCO1010001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Onco","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/ONCO1010001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}